Circulating tumor DNA analysis in the era of precision oncology

The spatial and temporal genomic heterogeneity of various tumor types and advances in technology have stimulated the development of circulating tumor DNA (ctDNA) genotyping. ctDNA was developed as a non-invasive, cost-effective alternative to tumor biopsy when such biopsy is associated with signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Rabih, Guibert, Nicolas, Oxnard, Geoffrey R., Tsimberidou, Apostolia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968778/
https://www.ncbi.nlm.nih.gov/pubmed/32010431
http://dx.doi.org/10.18632/oncotarget.27418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968778/
https://www.ncbi.nlm.nih.gov/pubmed/32010431
http://dx.doi.org/10.18632/oncotarget.27418

Ejemplares similares